Old Web
English
Sign In
Acemap
>
authorDetail
>
Sanghun Iwashiro
Sanghun Iwashiro
Bayer
Rivaroxaban
Medicine
Internal medicine
Stroke
Atrial fibrillation
6
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
2021
PLOS ONE
Takanori Ikeda
Satoshi Ogawa
Takanari Kitazono
Jyoji Nakagawara
Kazuo Minematsu
Susumu Miyamoto
Yuji Murakawa
Sanghun Iwashiro
Yutaka Okayama
Toshiyuki Sunaya
Kazufumi Hirano
Takanori Hayasaki
Show All
Source
Cite
Save
Citations (0)
Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings
2019
Journal of Thrombosis and Thrombolysis
Takanori Ikeda
Satoshi Ogawa
Takanari Kitazono
Jyoji Nakagawara
Kazuo Minematsu
Susumu Miyamoto
Yuji Murakawa
Sanghun Iwashiro
Yoko Kidani
Yutaka Okayama
Toshiyuki Sunaya
Shoichiro Sato
Satoshi Yamanaka
Show All
Source
Cite
Save
Citations (19)
1